Vamshi Gajjala, MD

Dr.Vamshi Gajjala is a healthcare and regulatory professional with experience in clinical care, pharmacovigilance, regulatory affairs, and laboratory research. He earned his medical degree from NTR University in India. He is currently pursuing an M.S. in Clinical Research Management at Rutgers University. His coursework focuses on clinical trial operations, GCP, regulatory compliance, study documentation, IRB oversight, informed consent, and safety reporting. He currently works as a U.S. Regulatory Affairs Specialist at Merck. In this role, he supports product registrations, CMC submissions, Veeva RIM data management, and the production of audit-ready regulatory documentation. He previously worked as a Pharmacovigilance Scientist at Guardian Drug Company, where he reviewed adverse drug experience cases, ICSRs, PADERs, and product quality complaints.

Before entering the pharmaceutical industry, Vamshi practiced as a Duty Medical Officer in India. He managed COVID-19 patients in outpatient, inpatient, and emergency care settings. He also completed clinical rotations across core medical departments, including dermatology. His interests include drug safety, clinical research, regulatory compliance, medical writing, and responsible use of technology in healthcare. His work relates closely to BRITE Institute’s mission to create safe AI for healthcare. His background connects clinical judgment, patient safety, regulatory documentation, and real-world healthcare decision-making. Through his work in pharmacovigilance and regulatory operations, he understands the need for accurate data, risk evaluation, transparency, and compliance. These principles are important for building AI tools that are safe, trustworthy, and useful in healthcare.

‍